期刊文献+

药理学发展促进新药研发 被引量:4

Development of pharmacology promotes new drug research and development
下载PDF
导出
摘要 药理学是连接医学与药学、基础与临床、生命科学与化学及材料科学等多学科的一门桥梁学科。药理学与多个学科有着密切的联系,是医药科学中不可或缺的重要学科,在医药科学的发展中始终发挥着重要作用。药理学学科发展的任务主要有合理用药、新药研发和促进医药科学和生命科学的进步3个方面。在新药研发的整个过程中,药理学发挥了积极作用;重视药理学的发展是保障新药研发的关键条件。从药物靶点和作用机制研究到药物发现、药理作用到有效性认识、药物体内过程评价到安全性评价及临床研究到指导临床应用,都是药理学研究的内容。因此,药理学对于促进新药研发、保障合理用药具有十分重要的意义。 Pharmacology is a bridge discipline between medicine and pharmacy,betmeen basic medicine and clinical medicine,between life sciences and chemistry as well as material science. Pharmacology is closely related to many subjects,and is an indispensable subject in medical sciences. It plays an important role in the development of medical sciences. The main tasks of pharmacology development involve rational drug use,new drug research and development,and promotion of medical sciences and life sciences. During the whole process of new drug development,the development of pharmacology has played a positive role. As such,new drug research and development depends on the development of pharmacology. Pharmacology plays an important role in the development of new drugs and is involved in the whole process of research and development. Thus,it is a support subject for new drug development. Strengthening pharmacological research and improving the overall level of pharmacological in China are of great significance for promoting new drug research and development and ensuring rational drug use.
作者 杜冠华
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2016年第12期1243-1249,共7页 Chinese Journal of Pharmacology and Toxicology
基金 国家科技重大专项(2013ZX09508104) 国家科技重大专项(2013ZX09402203) 国家科技重大专项(2013ZX09103001-008)~~
关键词 药理学 新药 研发 合理用药 pharmacology new drugs research and development rational drug use
  • 相关文献

参考文献8

二级参考文献211

  • 1Schoonen WG, Westerink WM, Horbach GJ. High-throughput screening for analysis of in vitro toxicity [J]. EXS, 2009, 99 : 401-452.
  • 2Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? [J]. Nat Rev Drug Discov, 2004, 3(8) :711-715.
  • 3Dragunow M. High-content analysis in neumscience[ J]. Nat Rev Neurosci, 2008, 9(10):779-788.
  • 4Xu JJ, Diaz D, O'Brien PJ. Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential[J]. Chem Biol Interact, 2004, 150( 1 ) :115-128.
  • 5Rausch O. High content cellular screening[J]. Curr Opin Chem Biol, 2006, 10(4) :316-320.
  • 6O'Brien PJ, Irwin W, Diaz D, Howard-Cofield E, Krejsa CM, Slaughter MR, et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell- based model using high content screening [ J ]. Arch Toxicol, 2006, 80(9) :580-604.
  • 7O'Brien P, Haskins JR. In vitro cytotoxicity assessment[ M] ff Taylor DL, Haskins JR, Giuliano KA. High Content Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery. Totova: Humana Press, 2007:424.
  • 8Kim JA, Han E, Eun CJ, Tak YK, Song JM. Real-time concur- rent monitoring of apoptosis, cytosolic calcium, and mitochondfia permeability transition for hypermulticolor high-content screening of drug-induced mitochondrial dysfunction-mediated hepatotoxicity [J]. Toxicol Left, 2012, 214(2) :175-181.
  • 9Tolosa L, Pinto S, Donato Mr, Ioz A, Castell JV, O'Connor JE, et al. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs [ J ]. Toxicol Sci, 2012, 127(1) :187-198.
  • 10Peng SQ, Hao WD, Wu YJ. Toxicology Alternative Method [M]. Beijing: Military Medical Science Press, 2008:396-430.

共引文献63

同被引文献49

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部